Cytotoxicity of endogenous lipids N-acyl dopamines and their possible metabolic derivatives for human cancer cell lines of different histological origin

Anticancer Research

Volumn 35, Issue 5, 2015, Pages 2657-2661

  Akimov, Mikhail G ^a   Gretskaya, Natalia M ^a   Zinchenko, Galina N ^a   Bezuglov, Vladimir V ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Cancer; Cytotoxicity; Metabolites; N acyl dopamine; Vanilloids

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; DOPAMINE; DOPAMINE AMIDE ARACHIDONIC ACID; DOPAMINE AMIDE DOCOSAHEXAENOIC ACID; DOPAMINE AMIDE OLEIC ACID; DOPAMINE AMIDE PROSTAGLANDIN E2; DOPAMINE AMIDE STEARIC ACID; DOPAMINE DERIVATIVE; DRUG METABOLITE; LONG CHAIN FATTY ACID; N ACYL DOPAMINE DERIVATIVE; N ARACHIDONOYL 3 O METHYL DOPAMINE; N ARACHIDONOYL EPINEPHRINE; N ARACHIDONOYL NOREPINEPHRINE; N ARACHIDONOYL O SULPHODOPAMINE; N ARACHIDONOYL TYRAMINE; UNCLASSIFIED DRUG; FATTY ACID; LIPID;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG CYTOTOXICITY; HEK293 CELL LINE; HISTOPATHOLOGY; HOS CELL LINE; HUMAN; HUMAN CELL; IMR 32 CELL LINE; INCUBATION TIME; K562 CELL LINE; LACTATE DEHYDROGENASE ASSAY; LD50; LYMPHOMA CELL LINE; MCF 7 CELL LINE; MTT ASSAY; NAMALWA CELL LINE; NEUROBLASTOMA CELL LINE; OSTEOSARCOMA CELL LINE; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; ANIMAL; GLIOBLASTOMA; METABOLISM; NEOPLASM; PATHOLOGY; STRUCTURE ACTIVITY RELATION;

ANIMALS; DOPAMINE; FATTY ACIDS; GLIOBLASTOMA; HEK293 CELLS; HUMANS; LIPIDS; MCF-7 CELLS; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84929670934     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bezuglov VV, Manevich Y, Archakov AV, Bobrov MYU, Kuklev DV, Petrukhina GN, Makarov VA and Buznikov GA: Artificially functionalized polyenoic fatty acids as new lipid bioregulators Russ J Bioorg Chem 23: 211-220, 1997.
2. Pokorski M and Matysiak Z: Fatty acid acylation of dopamine in the carotid body. Med Hypotheses 50: 131-133, 1998.
3. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM and Di Marzo V: An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors Proc Natl Acad Sci USA 99: 8400-8405, 2002.
4. Chu CJ, Huang SM, De Petrocellis L, Bisogno T, Ewing SA, Miller JD, Zipkin RE, Daddario N, Appendino G, Di Marzo V and Walker JM: N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia J Biol Chem 278: 13633-13639, 2003.
5. Ostroumova TV, Markova LN, Akimov MG, Gretskaia NM and Bezuglov VV: Docosahexaenoyl dopamine in freshwater hydra: effects on regeneration and metabolic changes. Ontogenez 41: 164-167, 2010.
6. Hauer D, Schelling G, Gola H, Campolongo P, Morath J, Roozendaal B, Hamuni G, Karabatsiakis A, Atsak P, Vogeser M and Kolassa I-T: Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. PLoS One 8: e62741, 2013.
7. Akimov MG and Bezuglov VV: N-Acylated Dopamines: A New Life for the Old Dopamine. In: Dopamine: Functions, regulation and health effects (Kudo E and Fujii Y (eds.). NY, Nova Science Publishers, pp 49-80, 2012.
8. Bobrov MYu, Lizhin AA, Andrianova EL, Gretskaya NM, Frumkina LE, Khaspekov LG and Bezuglov VV: Antioxidant and neuroprotective properties of N-arachidonoyldopamine. Neurosci Lett 431: 6-11, 2008.
9. Andrianova EL, Bobrov MYu, Gretskaya NM, Zinchenko GN, Serkov IV, Fomina-Ageeva EV and Bezuglov VV: The effects of neurolipins and their synthetic analogues on normal and transformed glial cells Neurochem J 4: 46-54, 2010.
10. Bisogno T, Melck D, Bobrov MYu, Gretskaya NM, Bezuglov VV, De Petrocellis L and Di Marzo V: N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo Biochem J 351 Pt 3: 817-824, 2000.
11. Liu X, Yamada N, Maruyama W and Osawa T: Formation of dopamine adducts derived from brain polyunsaturated fatty acids: Mechanism for Parkinson's disease. J Biol Chem 283: 34887-34895, 2008.
12. Visnyei K, Onodera H, Damoiseaux R, Saigusa K, Petrosyan S, De Vries D, Ferrari DB, Saxe J, Panosyan E, Masterman-Smith M, Mottahedeh J, Bradley KA, Huang J, Sabatti C, Nakano I and Kornblum HI: A molecular screening approach to identify and characterize inhibitors of glioblastoma multiforme stem cells. Mol Cancer Ther 2011.
13. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
14. Abe K and Matsuki N: Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT. Neurosci Res 38: 325-329, 2000.
15. Fritz AG: International classification of diseases for oncology: ICD-O. Geneva, World Health Organization, 2000.
16. Kavsan VM, Iershov AV and Balynska OV: Immortalized cells and one oncogene in malignant transformation: old insights on new explanation. BMC Cell Biol 12: 23, 2011.
17. Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V, D'argenio G, Scaglione G, Bifulco M, Sorrentini I and Di Marzo V: Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125: 677-687, 2003.
18. Burstein S and Salmonsen R: Acylamido analogs of endocannabinoids selectively inhibit cancer cell proliferation. Bioorg Med Chem 16: 9644-9651, 2008.
19. Shimada C, Uesawa Y, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, Nakashima H, Takao K, Miyashiro T, Sugita Y and Sakagami H: Quantitative structure-cytotoxicity relationship of piperic acid amides. Anticancer Res 34: 4877-4884, 2014.
20. Graham FL, Smiley J, Russell WC and Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74, 1977.
21. Lobner D: Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J Neurosci Methods 96: 147-152, 2000.
22. Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
23. Hail N: Mechanisms of vanilloid-induced apoptosis. Apoptosis 8: 251-262, 2003.
24. Akimov MG, Ashba AM, Gretskaya NM and Bezuglov VV: Some aspects of the Mechanism of Cell Death Induction by the Lipids of N-Acyl Dopamines Family in PC12 and C6 Cancer Cell Lines Anticancer Res 34: 5797-5800, 2014.